Bluebird Bio (NQ: BLUE )
0.9550
-0.0046
(-0.48%)
Streaming Delayed Price
Updated: 3:15 PM EDT, Jun 17, 2024
Add to My Watchlist
All News about Bluebird Bio![]() ![]() Via Benzinga
![]() ![]() ![]() ![]()
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Via Benzinga
Exposures
Product Safety
![]()
Bluebird Bio's Shares Drop To 52-Week Low After Another Gene Therapy Trial Placed On FDA Hold
August 09, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() From bluebird bio, Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() From bluebird bio, Inc.
Via Business Wire
![]() ![]()
FDA Gives Signal to Halted Bluebird Bio's Gene Therapy Trials In Sickle Cell Disease, Thalassemia
June 07, 2021
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|